Clinical Trial Update: A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients

View source ↗

Summary

A completed clinical trial provides a real-world analysis of patient characteristics, treatment patterns, and clinical outcomes among prostate cancer patients t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Pluvicto (lutetium-177 PSMA-617)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Prostate Cancer | Status: COMPLETED